The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Mullen, Alexander Balfour
    Pharmacist born in March 1968
    Individual (1 offspring)
    Officer
    2022-09-21 ~ now
    OF - director → CIF 0
    Mr Alexander Balfour Mullen
    Born in March 1968
    Individual (1 offspring)
    Person with significant control
    2022-09-21 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Chityala Narayana, Mallikarjun
    Director born in June 1976
    Individual (1 offspring)
    Officer
    2022-07-08 ~ now
    OF - director → CIF 0
    Mr Mallikarjun Chityala Narayana
    Born in June 1976
    Individual (1 offspring)
    Person with significant control
    2022-07-08 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Ceased 2
  • 1
    Devlin, Jodi
    Chairman And Consultant born in February 1962
    Individual
    Officer
    2022-09-21 ~ 2024-07-25
    OF - director → CIF 0
  • 2
    Suite 2, Ground Floor, Orchard Brae House, 30 Queensferry Road, Edinburgh
    Corporate (13 parents, 476 offsprings)
    Equity (Company account)
    2 GBP2024-03-31
    Officer
    2022-07-08 ~ 2023-04-24
    PE - secretary → CIF 0
parent relation
Company in focus

FITABEO THERAPEUTICS LIMITED

Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
72110 - Research And Experimental Development On Biotechnology
Brief company account
Par Value of Share
Class 1 ordinary share
02023-04-01 ~ 2024-03-31
Intangible Assets
385,389 GBP2024-03-31
58,357 GBP2023-03-31
Property, Plant & Equipment
18,554 GBP2024-03-31
22,044 GBP2023-03-31
Fixed Assets
403,943 GBP2024-03-31
80,401 GBP2023-03-31
Debtors
60,308 GBP2024-03-31
61,407 GBP2023-03-31
Cash at bank and in hand
81,515 GBP2024-03-31
354,611 GBP2023-03-31
Current Assets
141,823 GBP2024-03-31
416,018 GBP2023-03-31
Creditors
Current
160,309 GBP2024-03-31
131,878 GBP2023-03-31
Net Current Assets/Liabilities
-18,486 GBP2024-03-31
284,140 GBP2023-03-31
Total Assets Less Current Liabilities
385,457 GBP2024-03-31
364,541 GBP2023-03-31
Creditors
Non-current
455,514 GBP2024-03-31
400,000 GBP2023-03-31
Net Assets/Liabilities
-70,057 GBP2024-03-31
-35,459 GBP2023-03-31
Equity
Called up share capital
250 GBP2024-03-31
250 GBP2023-03-31
Retained earnings (accumulated losses)
-70,307 GBP2024-03-31
-35,709 GBP2023-03-31
Equity
-70,057 GBP2024-03-31
-35,459 GBP2023-03-31
Average Number of Employees
62023-04-01 ~ 2024-03-31
42022-07-08 ~ 2023-03-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
36,979 GBP2024-03-31
8,624 GBP2023-03-31
Development expenditure
348,410 GBP2024-03-31
49,733 GBP2023-03-31
Intangible Assets - Gross Cost
385,389 GBP2024-03-31
58,357 GBP2023-03-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
36,979 GBP2024-03-31
8,624 GBP2023-03-31
Development expenditure
348,410 GBP2024-03-31
49,733 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
24,100 GBP2024-03-31
24,100 GBP2023-03-31
Computers
2,767 GBP2024-03-31
800 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
26,867 GBP2024-03-31
24,900 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
7,632 GBP2024-03-31
2,812 GBP2023-03-31
Computers
681 GBP2024-03-31
44 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
8,313 GBP2024-03-31
2,856 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
4,820 GBP2023-04-01 ~ 2024-03-31
Computers
637 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
5,457 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
Plant and equipment
16,468 GBP2024-03-31
21,288 GBP2023-03-31
Computers
2,086 GBP2024-03-31
756 GBP2023-03-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
21,750 GBP2024-03-31
51,000 GBP2023-03-31
Other Debtors
Current, Amounts falling due within one year
38,558 GBP2024-03-31
10,407 GBP2023-03-31
Debtors
Current, Amounts falling due within one year
60,308 GBP2024-03-31
61,407 GBP2023-03-31
Trade Creditors/Trade Payables
Current
44,547 GBP2024-03-31
20,269 GBP2023-03-31
Other Taxation & Social Security Payable
Current
6,997 GBP2024-03-31
5,460 GBP2023-03-31
Other Creditors
Current
108,765 GBP2024-03-31
106,149 GBP2023-03-31
Non-current
455,514 GBP2024-03-31
400,000 GBP2023-03-31
  • FITABEO THERAPEUTICS LIMITED
    Info
    Registered number SC737809
    Suite 2, Orchard Brae House, 30 Queensferry Road, Edinburgh EH4 2HS
    Private Limited Company incorporated on 2022-07-08 (2 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-03
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.